Vulnerabilities

Search by TI id or any alias (CVE, GHSA), vendor, product or CWE.

Filters

Reset all

Threatist priority CRITICAL 0 HIGH 0 MEDIUM 0 LOW 2

Signals Exploited in the wild (KEV) 0 Patch available 2 No fix listed 0 Has CVE 2

Fix status Fixed 2 Partial 0 Will not fix 0 Deferred 0 No fix listed 0

Impact type Code execution 0 Privilege escalation 0 Security bypass 1 Information disclosure 0 Tampering 0 Denial of service 0 Spoofing 0 Cross-site scripting 0 SQL injection 0

Attack vector Network 1 Adjacent network 0 Local 1 Physical 0

Requirements No authentication 0 No user interaction 2

Product

Products as named in CPE, with their records.

Published Last 7 days Last 30 days Last 12 months Any time

Weakness (CWE) CWE-22 Improper Limitation of a Pathname to a Restricted Directory 1 CWE-284 Improper Access Control 1

1 selected

2 records

Sort

Release: Apple iOS and iPadOS, macOS, macOS 12.7, 13.6, 16.7 × Clear all filters

TI-2023-23036 CVE-2023-42961 · GHSA-cg4r-9g44-qvw4

Path traversal in Apple iOS and iPadOS

Priority LOW 28

A path handling issue was addressed with improved validation.

CVSS 3.1MEDIUM 6.3· Network · Low privileges · No interaction · EPSS 0.00452 · Published 2025-04-11 · Fixed in 17, 16.7 +3 CWE-22

TI-2023-23038 CVE-2023-42969 · GHSA-64h7-7273-jw5g

Improper access control in Apple iOS and iPadOS

Priority LOW 15

An app may be able to break out of its sandbox.

CVSS 3.1LOW 3.3· Local · Low privileges · No interaction · EPSS 0.00171 · Published 2025-04-11 · Fixed in 17, 16.7 +3 CWE-284

THREATIST.IO

Vulnerability intelligence for security teams and AI agents.

Vulnerabilities Vendors Exploited (KEV) API & MCP Newsletter Privacy policy Terms of use

Newsletter Vulnerability intelligence in your inbox Subscribe

© 2026 Threatist.io · X (@threatist)Data: CVE Program, NVD, CISA KEV, FIRST EPSS, GitHub Advisory Database and Red Hat security data (both CC BY 4.0), Microsoft Security Response Center. This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences

We would like to use Google Analytics cookies to see how the site is used. They are set only if you accept. Privacy policy